LOGIN  |  REGISTER
Chimerix

Recent Insider Transactions - Corvus Pharmaceuticals (NASDAQ: CRVS)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ CRVS Corvus Pharmaceuticals
Moore David Scott / director
10/02/2025
Buy
$7.04
30,000
$211K
30,000